Diosmetin

Alias: Luteolin 4-methyl ether;HSDB-8101;Diosmetin; HSDB 8101; HSDB 8101; Luteolin 4''-methyl ether
Cat No.:V0810 Purity: ≥98%
Diosmetin (also known as DIO; HSDB 8101; HSDB 8101; Luteolin 4-methyl ether)is a naturally occuring flavonoid found in spearmint, oregano, and many other plants with various biological activity (e.
Diosmetin Chemical Structure CAS No.: 520-34-3
Product category: P450 (e.g. CYP)
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
50mg
100mg
250mg
500mg
Other Sizes

Other Forms of Diosmetin:

  • Diosmetin-d3 (Diosmetin-d3)
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Product Description

Diosmetin (also known as DIO; HSDB 8101; HSDB 8101; Luteolin 4'-methyl ether) is a naturally occuring flavonoid found in spearmint, oregano, and many other plants with various biological activity (e.g, antioxidant, anti-inflammation, anticancer). It inhibits human CYP1A enzyme activity with an IC50 of 40 μM in HepG2 cell. Diosmetin is also an agonist of the aryl hydrocarbon receptor (AHR). It potently inhibited the enzyme activity of cytochrome P450 1A1 (CYP1A1) in a dose-dependent manner with an IC50 value of approximately 30 nM, in microsomes from MCF-7 cells.

Biological Activity I Assay Protocols (From Reference)
ln Vitro
HepG2 cell growth is inhibited by diosmetin in a concentration-dependent manner. HepG2 cells treated with diosmetin are distorted and some take on a round, floating appearance, whereas untreated cells develop normally and have a normal skeleton [1].
ln Vivo
In cerulein-induced acute pancreatitis, pretreatment with diosmetin significantly decreased serum levels of lipase and amylase, tissue damage, secretion of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6, myeloperoxidase (MPO) activity, trypsinogen-activating peptide (TAP) levels, expression of inducible nitric oxide synthase (iNOS), and nuclear factor (NF)-κB [2].
Animal Protocol
100 mg/kg
Mice: Experimental acute pancreatitis is induced in mice by seven intraperitoneal injection of cerulein (50 μg/kg) at hourly intervals. Diosmetin (100 mg/kg) or vehicle is pretreated 2 h before the first cerulein injection. After 6 h, 9 h, 12 h of the first cerulein injection, the severity of acute pancreatitis is evaluated biochemically and morphologically
References
[1]. Liu B, et al. Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells. Mol Med Rep. 2016 Jul;14(1):159-64.
[2]. Yu G, et al. Diosmetin ameliorates the severity of cerulein-induced acute pancreatitis in mice by inhibiting the activation of the nuclear factor-κB. Int J Clin Exp Pathol. 2014 Apr 15;7(5):2133-42
These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C16H12O6
Molecular Weight
300.26
CAS #
520-34-3
Related CAS #
Diosmetin-d3;1189728-54-8
SMILES
O1C2=C([H])C(=C([H])C(=C2C(C([H])=C1C1C([H])=C([H])C(=C(C=1[H])O[H])OC([H])([H])[H])=O)O[H])O[H]
Synonyms
Luteolin 4-methyl ether;HSDB-8101;Diosmetin; HSDB 8101; HSDB 8101; Luteolin 4''-methyl ether
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: 60 mg/mL (199.8 mM)
Water:<1 mg/mL
Ethanol:<1 mg/mL
Solubility (In Vivo)
Solubility in Formulation 1: ≥ 2.5 mg/mL (8.33 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: 10 mg/mL (33.30 mM) in 0.5% CMC-Na/saline water (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.3304 mL 16.6522 mL 33.3045 mL
5 mM 0.6661 mL 3.3304 mL 6.6609 mL
10 mM 0.3330 mL 1.6652 mL 3.3304 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Clinical Trial Information
NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT06256575 Not yet recruiting Combination Product:
Diosmin plus Diosmetin
Scleroderma, Systemic
Digital Ulcer
Primus Pharmaceuticals May 15, 2024 Not Applicable
Biological Data
  • Effect of diosmetin on pancreas pathology in cerulein induced AP. Mice (n=8 for each group) were given seven hourly injection of cerulein (50 ug/kg). Diosmetin (25 mg/kg, 50 mg/kg, 100 mg/kg; p.o.) or vehicle (p.o.) was administrated 2 h before the first cerulein injection. The control group was given saline (0.9% NaCl) solution intraperitoneally instead cerulein. Mice were sacrificed 12 h after the first injection of cerulein. Changes in serum amylase level (A) and lipase level (B). Data are represented as mean ± SD. #P < 0.05 vs control group, $P < 0.05 vs vehicle-treated group, &P < 0.05 vs 25 mg/kg group, *P < 0.05 vs 50 mg/kg group. (C) Effect of diosmetin on pancreas histology in cerulein-induced AP. Mice (n=24 for each group) were given seven hourly injection of cerulein (50 ug/kg). Diosmetin (100 mg/kg; p.o.) or vehicle (p.o.) was administrated 2 h before the first cerulein injection. The control group was given saline (0.9% NaCl) solution intraperitoneally instead cerulein. Mice were sacrificed 6 h, 9 h, 12 h after the first injection of cerulein, five mice at every time point in each group. Representative hematoxylin and eosin-stained sections of pancreas are shown. Original magnifications: 200×.
  • Diosmetin inhibits nuclear translocation of NF-κB. Pancreatic tissue expression level of NF-κB p65 protein in nucleus were detected by western blot (A, B). Histone H1 was used as the internal reference for nuclear proteins. Data are presented as mean ± SD. #P < 0.05 vs control group at the same time point, $P < 0.05 vs vehicle-treated group at the same time point. (C) Immunohistochemical analysis of NF-κB p65 in mouse pancreas at 6 h after induction of AP. Original magnifications: 400×.
  • Anti-inflammatory effect of diosmetin in cerulein-induced AP. Serum proinflammatory cytokine such as TNF-α, IL-β and IL-6 were measured by ELISA (A-C). Changes in pancreatic tissue MPO activity (D). Data are represented as mean ± SD. #P < 0.05 vs control group at the same time point, $P < 0.05 vs vehicle-treated group at the same time point.
Contact Us Back to top